SAFECODE DRUG TECHNOLOGIES CORP. Stock-Based Compensation
SAFECODE DRUG TECHNOLOGIES CORP. reported Stock-Based Compensation of $350.79 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2013-05-10
- SAFECODE DRUG TECHNOLOGIES CORP. share-based payment arrangement, noncash expense for the quarter ending 2013-03-31 was $350.79K.
- SAFECODE DRUG TECHNOLOGIES CORP. share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $0.00.
- SAFECODE DRUG TECHNOLOGIES CORP. share-based payment arrangement, noncash expense for fiscal 2012 was $120.15K.
- SAFECODE DRUG TECHNOLOGIES CORP. share-based payment arrangement, noncash expense for fiscal 2011 was $0.00.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 25 month | Share-based Payment Arrangement, Noncash Expense 28 month |
|---|---|---|---|---|
| 2013-03-31 | $350.79K 10-Q · filed 2013-05-10 | $470.94K 10-Q · filed 2013-05-10 | ||
| 2012-12-31 | $120.15K 10-K · filed 2013-03-25 | $120.15K 10-K · filed 2013-03-25 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-25 |